ישראל - עברית - Ministry of Health

dexcel ltd, israel - captopril - טבליה - captopril 50 mg - captopril - captopril - hypertension, congestive heart failure, insulin dependent diabetic nephropathy in hypertensive and non hypertensive patients in cases where the serum creatinine level < 2.5 mg/dl. left ventricular dysfunction after myocardial infarction. captopril is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction < or equals to 40 % and to reduce the incidence of overt heart failure and subsequent hospitalization for congestive heart failure in these patients.

ישראל - עברית - Ministry of Health

dexcel ltd, israel - enalapril maleate - טבליה - enalapril maleate 5 mg - enalapril - enalapril - treatment of essential hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. to retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.

ישראל - עברית - Ministry of Health

dexcel ltd, israel - enalapril maleate - טבליה - enalapril maleate 10 mg - enalapril - enalapril - treatment of essntial hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. to retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.

ישראל - עברית - Ministry of Health

dexcel ltd, israel - enalapril maleate - טבליה - enalapril maleate 20 mg - enalapril - enalapril - treatment of essential hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. to retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.

ישראל - עברית - Ministry of Health

dexcel ltd, israel - enalapril maleate; lercanidipine hydrochloride - טבליה - lercanidipine hydrochloride 10 mg; enalapril maleate 20 mg - enalapril - enalapril - treatment of essential hypertension in patients whose blood pressure cannot be adequately controlled under enalapril monotherapy.

ישראל - עברית - Ministry of Health

dexcel ltd, israel - enalapril maleate; lercanidipine hydrochloride - טבליה - lercanidipine hydrochloride 10 mg; enalapril maleate 10 mg - enalapril - enalapril - treatment of essential hypertension in whose blood pressure cannot be adequately controlled under lercanidipine monotherapy.

ישראל - עברית - Ministry of Health

dexcel pharma technologies ltd - losartan potassium - טבליה - losartan potassium 12.5 mg - losartan - losartan - hypertension: losardex is indicated for the treatment of hypertension. heart failure: losardex is indicated for the treatment of heart failure (nyha ii) , when treatment with an ace inhibitor is no longer considered appropriate. switching patients with heart failure who are stable on an ace inhibitor to losardex is not recommended.

ישראל - עברית - Ministry of Health

dexcel pharma technologies ltd - losartan potassium - טבליה - losartan potassium 50 mg - losartan - losartan - hypertension: losardex is indicated for the treatment of hypertension. heart failure: losardex is indicated for the treatment of heart failure (nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to losardex is not recommended. renal protection in type-2 diabetic patients with proteinuria: losardex is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease (need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventric

ישראל - עברית - Ministry of Health

dexcel pharma technologies ltd - losartan potassium - טבליה - losartan potassium 50 mg - losartan - losartan - hypertension: losardex is indicated for the treatment of hypertension. heart failure: losardex is indicated for the treatment of heart failure (nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to losardex is not recommended. renal protection in type-2 diabetic patients with proteinuria: losardex is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease (need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventric

ישראל - עברית - Ministry of Health

dexcel pharma technologies ltd - losartan potassium - קפליות - losartan potassium 100 mg - losartan - losartan - hypertension. losardex is indicated for the treatment of heart failure (nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to losardex is not recommended. renal protection in type-2 diabetic patients with proteinuria: losardex is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease (need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventricular hypertrophy. the benefit of losardex on the primary deposite endpoi